Your cart

There are no items in your shopping cart

JH-RE-06

Based on 4 reference(s) in Google Scholar 8 10 4

Axon 3002

CAS [1361227-90-8]

MF C20H16Cl3N3O4
MW 468.72

  • Purity: 99%
  • Soluble in 0.1N NaOH(aq) and DMSO

JH-RE-06

Description

JH-RE-06 is a compound disrupting REV1-POL ζ-mediated mutagenic translesion synthesis (TLS). Binding of JH-RE-06 induces REV1 dimerization, which blocks the REV1-REV7 interaction (IC50 value of 0.78 μM) and POL ζ recruitment. JH-RE-06 sensitizes tumors to cisplatin and reduces mutagenesis in vitro. Moreover, JH-RE-06 suppresses tumor progression in mice and prolongs animal survival.

KEYWORDS: JH-RE-06 | supplier | REV1-REV7 inhibitor | CAS [1361227-90-8] | DNA-RNA | DNA | Inhibitor | Enzymes

Specific and in vivo active REV1-REV7 interaction inhibitor

Chemical name

8-Chloro-2-(2,4-dichlorophenylamino)-3-(3-methylbutanoyl)-5-nitroquinolin-4(1H)-one

Parent CAS No.

[1361227-90-8]

Order
Size Unit Price Stock
5 mg €145.00 In Stock
25 mg €545.00 In Stock
Need more? Bulk Inquiry

Related Products

Axon ID Name Description From price
2965 PNR-7-02 Potent inhibitor of human DNA polymerase η €125.00
3008 AOH1160 First-in-class, potent and orally available PCNA inhibitor €120.00
3239 Entecavir Competitive inhibitor of HBV viral polymerase €50.00
3476 5-NIdR Potent inhibitor of translesion DNA synthesis (TLS) €120.00
3506 Vidarabine Inhibitor of herpes virus DNA polymerase €50.00
4003 RP-6685 Potent, selective, and orally bioavailable Polθ inhibitor €160.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...